Efficacy and Safety of Ruxolitinib in Regularly Transfused Patients with Thalassemia: Results from Single-Arm, Multicenter, Phase 2a Truth Study


AYDINOK Y., Karakas Z. , Cassinerio E., Siritanaratkul N., Kattamis A., Maggio A., ...More

58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 3 - 06 December 2016, vol.128 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 128
  • Doi Number: 10.1182/blood.v128.22.852.852
  • City: California
  • Country: United States Of America